IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Aug 2023 (Vol: 2023, Issue: 8)

Next Issue >>

Section: Licensing
Agios signs US$147.5 M License Deal with Alnylam’s RNAi therapeutic for Polycythemia Vera Published: 22 Aug-2023
By: Shweta Gupta
Abstract Fulltext:
Section: Mergers & Acquisitions
Biogen to Acquire Reata for US$7.3 B for Rare Disease Portfolio Published: 1 Aug-2023
By: Lalit Mishra
Abstract Fulltext:
Section: Research & Development
Roche Signs US$2.8 B Deal with Alnylam to Develop RNAi Therapeutic for Hypertension Published: 2 Aug-2023
By: Amit Kaushik
Abstract Fulltext:
Astellas Enters into Collaborations with PeptiDream and Cullgen to Advance Targeted Protein Degraders Published: 8 Aug-2023
By: Ashish Tripathi
Abstract Fulltext:

PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.

Login

Username:

Password:

Keep me logged in